Literature DB >> 26407782

Factors contributing to the increasing placebo response in antidepressant trials.

Siegfried Kasper1, Markus Dold1.   

Abstract

Year:  2015        PMID： 26407782      PMCID： PMC4592649          DOI： 10.1002/wps.20245

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  11 in total

1.  Placebo-controlled trials in major depression are necessary and ethically justifiable: how to improve the communication between researchers and ethical committees.

Authors:  Dieter Adam; S Kasper; H-J Möller; E A Singer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-12-24       Impact factor: 5.270

2.  The clinical significance of antidepressant treatment effects cannot be derived from placebo-verum response differences.

Authors:  U Hegerl; R Mergl
Journal:  J Psychopharmacol       Date:  2009-10-13       Impact factor: 4.153

Review 3.  Meta-analysis: fact or fiction? How to interpret meta-analyses.

Authors:  Wolfgang Huf; Klaudius Kalcher; Gerald Pail; Michaela-Elena Friedrich; Peter Filzmoser; Siegfried Kasper
Journal:  World J Biol Psychiatry       Date:  2011-03-04       Impact factor: 4.132

4.  A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depression.

Authors:  S A Montgomery; J G Rasmussen; P Tanghøj
Journal:  Int Clin Psychopharmacol       Date:  1993       Impact factor: 1.659

Review 5.  Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses.

Authors:  Stefan Leucht; Sandra Hierl; Werner Kissling; Markus Dold; John M Davis
Journal:  Br J Psychiatry       Date:  2012-02       Impact factor: 9.319

Review 6.  Placebo response in studies of major depression: variable, substantial, and growing.

Authors:  B Timothy Walsh; Stuart N Seidman; Robyn Sysko; Madelyn Gould
Journal:  JAMA       Date:  2002-04-10       Impact factor: 56.272

Review 7.  A model of placebo response in antidepressant clinical trials.

Authors:  Bret R Rutherford; Steven P Roose
Journal:  Am J Psychiatry       Date:  2013-07       Impact factor: 18.112

8.  A meta-analysis of factors impacting detection of antidepressant efficacy in clinical trials: the importance of academic sites.

Authors:  Boadie W Dunlop; Michael E Thase; Chuan-Chuan Wun; Rana Fayyad; Christine J Guico-Pabia; Jeff Musgnung; Philip T Ninan
Journal:  Neuropsychopharmacology       Date:  2012-08-22       Impact factor: 7.853

9.  Antidepressants versus placebo in major depression: an overview.

Authors:  Arif Khan; Walter A Brown
Journal:  World Psychiatry       Date:  2015-10       Impact factor: 49.548

10.  Less is more in antidepressant clinical trials: a meta-analysis of the effect of visit frequency on treatment response and dropout.

Authors:  Bret R Rutherford; Timothy M Cooper; Amanda Persaud; Patrick J Brown; Joel R Sneed; Steven P Roose
Journal:  J Clin Psychiatry       Date:  2013-07       Impact factor: 4.384
View more
  5 in total

1.  Has the rising placebo response impacted antidepressant clinical trial outcome? Data from the US Food and Drug Administration 1987-2013.

Authors:  Arif Khan; Kaysee Fahl Mar; Jim Faucett; Shirin Khan Schilling; Walter A Brown
Journal:  World Psychiatry       Date:  2017-06       Impact factor: 49.548

2.  WPA Scientific Sections: update on the activities.

Authors:  Afzal Javed
Journal:  World Psychiatry       Date:  2016-06       Impact factor: 49.548

Review 3.  Using Artificial Intelligence-based Methods to Address the Placebo Response in Clinical Trials.

Authors:  Erica A Smith; William P Horan; Dominique Demolle; Peter Schueler; Dong-Jing Fu; Ariana E Anderson; Joseph Geraci; Florence Butlen-Ducuing; Jasmine Link; Ni A Khin; Robert Morlock; Larry D Alphs
Journal:  Innov Clin Neurosci       Date:  2022 Jan-Mar

4.  Treatment Response of Add-On Esketamine Nasal Spray in Resistant Major Depression in Relation to Add-On Second-Generation Antipsychotic Treatment.

Authors:  Markus Dold; Lucie Bartova; Siegfried Kasper
Journal:  Int J Neuropsychopharmacol       Date:  2020-07-29       Impact factor: 5.176

Review 5.  Placebo Effect in Obsessive-Compulsive Disorder (OCD). Placebo Response and Placebo Responders in OCD: The Trend Over Time.

Authors:  Georgios D Kotzalidis; Antonio Del Casale; Maurizio Simmaco; Lucia Pancheri; Roberto Brugnoli; Marco Paolini; Ida Gualtieri; Stefano Ferracuti; Valeria Savoja; Ilaria Cuomo; Lavinia De Chiara; Alessio Mosca; Gabriele Sani; Paolo Girardi; Maurizio Pompili; Chiara Rapinesi
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.